ArriVent BioPharma, Inc.
Public company- Headquarters
- NEWTOWN SQUARE, Pennsylvania
- Ticker
- AVBP
- CIK
- 0001868279
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
2
0 appointments, 1 departure
Last event
Nov 9, 2026
Executive departurePresident, Research and Development departs: Stuart Lutzker, M.D., Ph.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| President, Research and DevelopmentStuart Lutzker, M.D., Ph.D. | Nov 9, 2026 | Departed |
| leading the Company’s research and development functionPriti Patel, M.D. | Nov 9, 2026 | Role change |
Related companies
Same industry and state, with recent events.
- MADRIGAL PHARMACEUTICALS, INC.
Class II director appointed: John C. Reed, M.D., Ph.D.
- GeoVax Labs, Inc.
director appointed: Shahin Behroyan
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
No events of this type on record.
Show all eventsLast verified Nov 10, 2026